Hybrid-FenuMat is a patented, food-grade hydrogel delivery technology that uses a fenugreek galactomannan scaffold to encapsulate micelles. This system overcomes the poor bioavailability of hydrophobic compounds like fisetin, providing a sustainable, clean-label, and highly effective delivery format for diverse nutraceuticals. Supported by extensive clinical research, it allows for significantly enhanced absorption, stability, and controlled release of active ingredients.
Hybrid-FenuMat is a food-grade, plant-based delivery technology that significantly enhances the bioavailability and stability of poorly absorbed nutrients, such as the flavonoid fisetin. By encapsulating fisetin micelles within a protective fenugreek galactomannan (FG) hydrogel scaffold, the system creates a nature-mimetic "hydrogel trap." This protective matrix safeguards active ingredients from harsh gastrointestinal environments and digestive enzymes, allowing for sustained, controlled delivery and higher absorption rates. The technology enables lower dosage requirements while maximizing therapeutic efficacy, making it an ideal solution for nutraceutical and functional food applications.
The University of Nottingham is a comprehensive public research university and Russell Group member based in Nottingham, with campuses in China and Malaysia, enabling international collaboration and talent pipelines. Industry partners engage through an on-campus research and technology park that co-locates companies with university groups, plus shared-use facilities and pilot spaces for scale-up. Integration with a major NHS hospital system supports clinical trials and translation, while placements and professional programs connect companies with student and graduate talent. Research is supported by competitive funding from UKRI research councils and Innovate UK, with added support through NHS partnerships and European programs. A dedicated technology transfer office manages IP, licensing, and spinout formation.